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Abstract: Two novel carbazole alkaloids, guillauminines A and B (1 and 2), and sixteen known 
compounds were isolated and identified from the acetone extract of Clausena guillauminii roots. 
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antimycobacterial activities of the isolated compounds were evaluated. 
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1. Introduction 
Clausena is an abundant source of secondary metabolites, especially carbazole alkaloids 
(Maneerat et al., 2011, 2012, 2013; Songsiang et al., 2011, 2012; Thongthoom et al., 2010), 
coumarins (Maneerat et al., 2012; Songsiang et al., 2011, 2012; Thongthoom et al., 2010) and 
amide derivitives (Riemer et al., 1997; Wang et al., 2013). Many of the isolated compounds have 
a wide range of pharmacological activities including anticancer (Maneerat et al., 2012, 2013; 
Songsiang et al., 2011; Thongthoom et al., 2010), anti-HIV (Kongkathip et al., 2005, 2010; Krahl 
et al., 2006), anti-malarial (Maneerat et al., 2011; Thongthoom et al., 2010) and anti-TB 
(Maneerat et al., 2011; Thongthoom et al., 2010). In this paper, we investigated the 
phytochemicals from the roots of Clausena guillauminii (Rutaceae family), which led to the 
isolation and characterization of two new carbazole alkaloids (1 and 2) along with sixteen known 
compounds (3-18). The structures of the isolated compound were elucidated using spectroscopic 
methods especially 1D and 2D NMR spectroscopy. The structures of the known compounds 
were determined and confirmed by comparison of their 1H and/or 13C spectroscopic data with 
those reported in the literature. The cytotoxic, antimalarial and antimycobacterial activities of the 
isolated compounds were examined. 
2. Results and discussion 
Investigation of the acetone extract from the air-dired roots C. guillauminii led to the 
isolation of two new carbazole alkaloids, guillauminines A and B (1 and 2); fourteen known 
carbazole alkaloids, heptahylline (3) (Songsiang et al., 2012), 7-methoxyheptaphylline (4) 
(Songsiang et al., 2012), 3-formyl-7-hydroxy-9H-carbazole (5) (Ito et al., 1992; Krahl et al., 
2006), fluroclausine A (6) (Wu et al., 1997),  mukonal (7) (Thongthoom et al., 2010), 7-
methoxymukomal (8) (Songsiang et al., 2012), clauszoline K (9) (Thongthoom et al., 2010), 7-
methoxymurrayacine (10) (Songsiang et al., 2012), clauraila D (11) (Songsiang et al., 2011), 
heptazoline (12) (Songsiang et al., 2012), glycosinine (13) (Thongthoom et al., 2010), 7-
hydroxyheptaphylline (14) (Songsiang et al., 2012), 3-formyl-2,7-dimethoxycarbazole (15) 
(Ruangrungsi et al., 1990) and clauszoline C (16) (Krahl et al., 2013); and two known coumarins, 
osthol (17) (Thongthoom et al., 2010) and xanthoxyletin (18) (Songsiang et al., 2012) (Fig. 1).  
Guillauminine A (1) was obtained as a yellow solid with [α]D24 -0.06° (c 0.04, MeOH) 
and mp 234.0-235.0 °C. Its molecular formula, C19H19NO5, was deduced from HRESI-TOFMS. 
The IR spectrum indicated the presence of a hydroxyl, amine and aldehyde groups at 3366, 3212 
and 1653 cm-1, respectively (Wu et al., 1997 and Thongthoom et al., 2010). The UV spectrum 
revealed the maxima absorption bands at λmax 241, 279, 301 and 347 nm indicating that 1 had a 
carbazole alkaloid chromophore (Maneerat et al., 2011, 2012, 2013; Songsiang et al., 2011, 
2012; Thongthoom et al., 2010). The 1H NMR spectrum (Table 1) displayed characteristic 
signals for an aldehyde proton (δ 10.42, s, 1H), an amino proton (δ 10.32, br s, 1H), three 
aromatic protons of a 1,2,4-trisubstituted benzene ring [δ 7.96 (d, J = 8.5 Hz, 1H, H-5), 7.14 (d, J 
= 2.1 Hz, 1H, H-8) and 6.83 (dd, J = 8.5, 2.1 Hz,1H, H-6)], a singlet aromatic proton (δ 8.30, s, 
1H, H-4), two oxymethine protons [δ 4.96 (d, J = 7.9 Hz, 1H, H-4') and δ 3.82 (d, J = 7.9 Hz, 
1H, H-3')], a methoxy group (δ 3.84, s, 3H) and two methyl groups (δ 1.56 and 1.32, each s, 3H). 
Compound 1 showed nine quaternary (δ 160.0, 154.2, 144.9, 143.3, 119.0, 118.7, 117.9, 107.6 
and 80.9), seven methine (δ 188.9, 121.4, 119.4, 109.5, 96.7, 76.8 and 69.4) and three methyl (δ 
55.8, 27.0 and 19.5) carbons in the 13C NMR and DEPT 135 spectra (Table 1). The aromatic 
protons at δ 7.96, 7.14 and 6.83 were assigned to be H-5, H-8 and H-6, respectively, due to their 
multiplicity and HMBC correlations (Table 1), H-5/C-4a (δ 118.7), C-4b (δ 119.0), C-7 (δ 160.0) 
and C-8a (δ 143.3), H-8/ C-4b, C-6 (δ 109.5), C-7 and C-8a and H-6/C-4b, C-7 and C-8 (δ 96.7). 
The methoxy group resonating at δ 3.84 was located at C-7 (δ 160.0) on the basis of the HMBC 
cross peak between the methoxy protons with C-7 and the chemical shifts of C-6 and C-8. The 
aldehyde proton, (δ 10.42), showed HMBC cross peaks with C-3 (δ 117.9) and C-4 (δ 119.4), 
suggesting the location of the formyl group at C-3. The singlet aromatic proton at δ 8.30 was 
assigned to H-4 according to its HMQC cross peak with C-4 (δ 119.4) as well as the HMBC 
correlations with C-2 (δ 154.2), C-3 (δ 117.9), C-9a (δ 144.9) and the aldehyde carbon (δ 188.9). 
In the 1H-1H COSY spectrum, the oxymethine proton, H-4' (δ 4.96) coupled with the other 
oxymethine proton, H-3' (δ 3.82), which correlated with C-2' (δ 80.9), C-4' (δ 69.4), C-5' (δ 27.0) 
and C-6' (δ 19.5) in the HMBC spectrum. These data together with the chemical shift of C-2 and 
the HMBC cross peaks H-4'/C-1 (δ 107.6), C-2 (δ 154.2) and C-9a (δ 144.9) indicated that a 
dimethylchromane ring with dihydroxy groups at C-3' and C-4' was fused at C-1 and C-2 of the 
carbazole nucleus with an ether linkage at C-2. The oxymethine protons, H-3' and H-4', were 
located in pseudoaxial positions on the basis of the large coupling constant of 7.9 Hz between H-
3' and H-4' (Wu et al., 1997).  
Guillauminine B (2) was obtained as a brown solid with [α]D24 -1.15° (c 0.05, MeOH) 
and mp 145.0-147.0 °C. Its molecular formula, C19H19NO4, was deduced from HRESI-TOFMS. 
The IR, UV, 1H and 13C NMR spectral data were similar to those of compound 1 and the 
spectroscopic data compound 2 was almost identical to that of synthetic 2 reported ealier 
(Thongthoom et al., 2011).  
Guillauminines A and B (1 and 2) have similar structures to clausines W and T (Wu et 
al., 1997), respectively, with replacement the hydroxyl group at C-7 in these known alkaloids 
with a methoxyl group in 1 and 2. The absolute configuration in compounds 1 and 2 should be 
racemic, which found to have low specific rotation, [α]D24 -0.06° (c 0.04, MeOH) and [α]D24 -
1.15° (c 0.05, MeOH), respectively. 
In a previous report, two known carbazole alkaloids (3 and 4) and three coumarins 
(poncitrin, 17 and 18) were isolated from the roots of C. guillauminii (Nakamura et al., 2009). 
Poncitrin and 17 inhibited iNOS protein expression while 18 inhibited TNF-α, and COX-2 
expression in mouse macrophage RAW 264.7 (Nakamura et al., 2009). In contrast, our study 
revealed the isolation of sixteen carbazole alkaloids (1-16) from this same plant. All isolated 
compounds were evaluated for their cytotoxicity against two human cancer lines, NCI-H187 
(small cell lung cancer) and KB (oral cavity cancer), Vero cell lines (African green monkey 
kidney, normal cells) (Table 2) and their antimalaria (against Plasmodium falciparum) and 
antimycobacterial (against Mycobacterium tuberculosis) activities.  
Compounds 2-3, 5, 9, 10, 15 and 18 were inactive to all tested cell lines (NCI-H187, KB, 
Vero cell, P. falciparum and M. tuberculosis). Compounds 6 and 14 displayed the highest 
cytotoxic activities against the NCI-H187 cell line with IC50 values of 7.44 and 9.51 µg/mL, 
respectively. Compound 6 showed stronger activity against KB cell line with an IC50 value of 
1.35 µg/mL. In addition compound 7 was non cytotoxic to the Vero cell line. Furthermore, 
compounds 7, 8 and 11 exhibited antimalaria activity with IC50 values of 4.03, 3.46 and 3.41 
µg/mL, respectively, as well as compounds 6 and 14 displayed weak antimycobacterial with the 
same IC50 value of 25 µg/mL. 
3. Experimental 
3.1 General 
Optical rotations were measured in MeOH at the sodium D-line on a Bellingham & Stanley ADP220 
polarimeter. UV-vis absorption spectra were determined in MeOH with a Perkin-Elmer UV-vis 
spectrophotometer. The infrared (IR) spectra were recorded on neat samples using a Perkin-Elmer FTS 
FT-IR spectrophotometer. 1H and 13C NMR spectra were recorded on a 400 MHz Bruker FTNMR Ultra 
Shield spectrometer. Chemical shifts are expressed in δ (ppm) referring to the tetramethylsilane (TMS) 
peak. Mass data were obtained on a MicroTOF, Bruker Daltonics mass spectrometer. Melting point were 
measured on a SANYO Gallenkamp melting point apparatus. Thin-layer chromatography (TLC) was 
performed on silica gel 60 GF254 (Merck). Column chromatography (CC) was carried out on Sephadex 
LH-20, and silica gel (Merck) type 100 (63-200 µm) and type (5-40 µm for QCC). All solvents for 
extraction and chromatography were routinely distilled prior to use. 
3.2 Plant material 
The roots of C. guillauminii were collected at Nong Khai Province, Thailand in March 2011. 
The plant was identified by Mr. James Maxwell and Dr. Monthon Norsaengsri. Voucher 
specimen numbers QBG 45329 and QBG 45330 were deposited at the herbarium collection of 
Queen Sirikit Botanic Garden, Mae Rim, Chiang Mai, Thailand. 
3.3 Extraction and isolation 
The dried roots of C. guillauminii (9.7 kg) were extracted with acetone over a period of 3 
days at room temperature. Removal of the solvent under reduced pressure provided the acetone 
extract (385.3 g) as a dark brown gum. The crude extract was separated by QCC over silica gel 
and eluted with a gradient of hexanes-CH2Cl2-acetone to give ten fractions (A–J). Fraction B (1.5 
g) was washed with hexanes to give compound 3 (326.0 mg) as a yellow solid. Fraction D (7.6 g) 
was further purified by CC over silica gel with 15% EtOAc-hexanes to afford four subfractions 
(D1-D4). Compounds 4 (1.0 g), 17 (316.0 mg) and 18 (77.4 mg) were obtained from subfraction 
D2 (2.5 g) after purification by CC over Sephadex LH-20 with MeOH/CH2Cl2 (4:1). Fraction F 
(4.5 g) was isolated by QCC with a gradient of hexanes-acetone giving four subfractions (F1-
F4). Subfraction F2 (139.8 mg) was fractionated by CC over silica gel with CH2Cl2/hexanes 
(4:1) to afford five subfractions (F2A-F2E). Compound 5 (2.3 mg) was contained in the second 
subfraction. Compound 2 (3.0 mg) was purified from the subfraction F2C after CC over silica gel 
eluted with EtOAc/CH2Cl2 (1:4). Subfraction F3 (551.2 mg) was separated by QCC with 
EtOAc/CH2Cl2 (1:9) giving five subfractions (F3A-F3E). The second subfraction (119.0 mg) was 
further purified by CC over silica gel with EtOAc/CH2Cl2 (1:4), followed by Sephadex LH-20 
CC with 100% MeOH to provide compounds 2 (7.5 mg) and 6 (8.2 mg). Compound 1 (14.0 mg) 
was purified from the fourth subfraction (61.8 mg) after separation using Sephadex LH-20 CC 
with 100% MeOH. Fraction G (6.7 g) was isolated by CC over silica gel with EtOAc/hexanes 
(1:4) to give five subfractions (G1-G5). Compound 7 (20.5 mg) was purified from subfraction 
G2 (183.3 mg) after separation by Sephadex LH-20 CC with 100% MeOH. Subfraction G4 (1.8 
g) was fractionated by CC over silica gel with EtOAc/hexanes (1:4) giving five subfractions 
(G4A-G4E). Compound 8 (56.3 mg) was obtained from the last subfraction. Compounds 7 (4.0 
mg) and 9 (6.3 mg) were obtained from the third subfraction (200.0 mg) after purification by CC 
over silica gel with EtOAc/hexanes (3:7). Fraction I (35.8 g) was further purified by QCC with a 
gradient of hexanes-CH2Cl2-EtOAc to give six subfractions (I1-I6). Purification of subfraction I2 
(273.0 mg) by CC over silica gel with CH2Cl2/hexanes (4:1) gave four subfractions (I2A-I2D). 
Compound 13 (66.0 mg) was contained in the first subfraction. The second subfraction (51.6 mg) 
was further purified by Sephadex LH-20 CC with 100% MeOH to give compound 10 (2.0 mg). 
Compounds 11 (2.0 mg) and 12 (8.0 mg) were achieved from subfraction I2B by CC over silica 
gel with EtOAc/hexanes (1.5:8.5). Subfraction I4 (10.0 g) was isolated by QCC with a gradient 
of hexanes-CH2Cl2 to give six subfractions (I4A-I4F). Compound 14 (100.0 mg) was purified 
from the first subfraction after isolation using CC over silica gel with acetone/CH2Cl2 (1:49). 
Subfractions I4C (2.5 g) was further purified by CC over silica gel with acetone/hexanes (1:49) 
to provide five subfractions (I4CA-I4CE). Compound 16 (9.3 mg) was obtained in the first 
subfraction. The second subfraction (119.0 mg) was further purified by Sephadex LH-20 CC 
with 100% MeOH to give compound 15 (43.0 mg). 
3.3.1 Guillauminine A (1) 
Yellow solid; mp. 234.0-235.0 °C; [α]D25 -0.06° (c 0.05, MeOH); UV (MeOH) λmax nm (log 
ε) 347 (3.82), 301 (4.19), 279 (4.14), 241 (4.29); IR (KBr) νmax cm-1 3366, 3212, 1653; 1H-NMR 
(400 MHz, Acetone-d6) and 13C-NMR (100 MHz, Acetone-d6) see Table 1; HRMS m/z: 
364.1147 [M+Na]+ (calcd. for C19H19NO5+Na, 364.1161). 
3.3.2 Guillauminine B (2) 
Brown solid; mp. 145.0-147.0 °C; [α]D24 -1.15° (c 0.04, MeOH); UV (MeOH) λmax nm (log 
ε) 345 (3.86), 301 (4.17), 279 (4.17), 241 (4.36); IR (KBr) νmax cm-1 3360 , 3179, 1653; 1H-NMR 
(400 MHz, Acetone-d6) and 13C-NMR (100 MHz, Acetone-d6) see Table 1; HRMS m/z: 
348.1216 [M+Na]+ (calcd. for C19H19NO4+Na, 348.1212). 
3.4 Bioactivity assays 
The activities against KB and NCI-H187 cell lines were evaluated using the resazurin 
microplate assay (O’Brien et al., 2000). The activity assay against African green monkey kidney 
fibroblast (Vero) cells was performed in triplicate employing the method described by Hunt et 
al., 1999. The in vitro anti-malaria activity against Plasmodium falciparum (K1, multidrug-
resistant strain) was assessed using the microculture radioisotope technique described by 
Desjardins et al., 1979. The standard compounds were dihydroartemisinin and mefloquine. The 
antimycobacterial activity was performed against Mycobacterium tuberculosis H37Ra strain 
using the green fluorescent protein microplate assay (GFPMA) by Collins and Franzblau, 1997. 
The standard compounds, rifampicin, streptomycin, isoniazid, ofloxacin and ethambutol, were 
used as the reference substances. 
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Fig. 1. Structures of the isolated compounds 1-18 from C. guillauminii roots. 
 
 
 
Table 1 NMR spectral data of guillauminines A and B (1 and 2) in acetone-d6 at 400 MHz 
Position 
1 2 
δH (mult., J in Hz) δC  HMBC  δH (mult., J in Hz) δC  HMBC 
1 − 107.6  −  − 103.7  − 
2 − 154.2  −  − 154.6  − 
3 − 117.9  −  − 120.6  − 
4 8.30 (s) 119.4 CH C-2, C-3, C-9a, CHO  8.24 (s) 117.9 CH C-2, C-9a, CHO 
4a − 118.7  −  − 120.9   − 
4b − 119.0  −  − 119.3  − 
5 7.96 (d, 8.5) 121.4 CH C-4a, C-4b, C-7, C-8a  7.97 (d, 8.5) 121.4 CH C-4a, C-7, C-8a 
6 6.83 (dd, 8.5, 2.1) 109.5 CH C-4b, C-7, C-8  6.84 (dd, 8.5, 2.1) 109.3 CH C-4b, C-8 
7 − 160.0  −  − 159.9  − 
8 7.14 (d, 2.1) 96.7 CH C-4b, C-6, C-7, C-8a  7.00 (d, 2.1) 96.4 CH C-4b, C-6, C-7, C-8a 
8a − 143.3  −  − 143.2  − 
9a − 144.9  −  − 145.1  − 
2' − 80.9  −  − 79.0  − 
3' 3.82 (d, 7.9) 76.8 CH C-2', C-4', C-5', C-6'  4.01 (m)  69.1 CH C-2', C-5', C-6' 
4' 
 
4.96 (d, 7.9) 
− 
69.4 
− 
CH C-1, C-2, C-9a, C-3' 
− 
a 3.23 (dd, 16.5, 5.7) 
2.90 (dd, 16.5, 7.2) 
28.1 CH2 C-1, C-2, C-9a 
C-2', C-3' b 
5'  1.56 (s) 27.0 CH3 C-2', C-3', C-6'  1.48 (s) 20.7 CH3 C-2', C-3', C-6' 
6' 1.32 (s) 19.5 CH3 C-2', C-3', C-5'  1.38 (s) 25.9 CH3 C-2', C-3', C-5' 
CHO 10.42 (s) 188.9 CH C-3, C-4  10.46 (s) 189.9 CH C-3, C-4 
7-OMe 3.84 (s) 55.8 CH3 C-7  3.85 (s) 55.8 CH3 C-7 
3'-OH − − −  4.53 (d, 5.4) − − 
9-NH 10.32 (br s) − −  10.44 (br s) − − 
 
 
 
